A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer

ABSTRACT: To assess the safety and tolerability of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer Who Are Refractory or Intolerant to Standard Chemotherapy

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2140859 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR